{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:55:28Z","timestamp":1789829728525,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T00:00:00Z","timestamp":1444867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L017105\/1"],"award-info":[{"award-number":["MR\/L017105\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/J01219X\/1"],"award-info":[{"award-number":["MR\/J01219X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00787-015-0780-7","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T12:25:18Z","timestamp":1444911918000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Clinical predictors of antipsychotic use in children and adolescents with autism spectrum disorders: a historical open cohort study using electronic health records"],"prefix":"10.1007","volume":"25","author":[{"given":"Johnny","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hotopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamsin","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Simonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,15]]},"reference":[{"key":"780_CR1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00213-013-3263-x","volume":"231","author":"Y Hsia","year":"2013","unstructured":"Hsia Y, Wong AYS, Murphy DGM et al (2013) Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology 231:999\u20131009","journal-title":"Psychopharmacology"},{"key":"780_CR2","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1542\/peds.2012-0900D","volume":"130","author":"DL Coury","year":"2012","unstructured":"Coury DL, Anagnostou E, Manning-Courtney P et al (2012) Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics 130:S69\u2013S76","journal-title":"Pediatrics"},{"key":"780_CR3","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1542\/peds.2007-0984","volume":"121","author":"DS Mandell","year":"2008","unstructured":"Mandell DS, Morales KH, Marcus SC et al (2008) Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics 121:e441\u2013e448","journal-title":"Pediatrics"},{"key":"780_CR4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00213-013-3140-7","volume":"231","author":"ML Murray","year":"2013","unstructured":"Murray ML, Hsia Y, Glaser K et al (2013) Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology 231:1011\u20131021","journal-title":"Psychopharmacology"},{"key":"780_CR5","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.ridd.2013.05.028","volume":"34","author":"CJ Bachmann","year":"2013","unstructured":"Bachmann CJ, Manthey T, Kamp-Becker I et al (2013) Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany. Res Dev Disabil 34:2551\u20132563","journal-title":"Res Dev Disabil"},{"key":"780_CR6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1542\/peds.2007-2008","volume":"121","author":"F Rani","year":"2008","unstructured":"Rani F, Murray ML, Byrne PJ, Wong IC (2008) Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121:1002\u20131009","journal-title":"Pediatrics"},{"key":"780_CR7","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","volume":"127","author":"ML McPheeters","year":"2011","unstructured":"McPheeters ML, Warren Z, Sathe N et al (2011) A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127:e1312\u2013e1321","journal-title":"Pediatrics"},{"key":"780_CR8","unstructured":"American Academy of Child and Adolescent Psychiatry Policy Statement on Comorbidity Treatment in Autism Spectrum Disorders and Intellectual Disabilities. http:\/\/www.aacap.org\/aacap\/Policy_Statements\/2013\/Comorbidity_Treatment_in_Autism_Spectrum_Disorders_and_Intellectual_Disabilities.aspx . Accessed 11 Jul 2015"},{"key":"780_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00787-010-0150-4","volume":"20","author":"A Stringaris","year":"2011","unstructured":"Stringaris A (2011) Irritability in children and adolescents: a challenge for DSM-5. Eur Child Adolesc Psychiatry 20:61\u201366","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"780_CR10","unstructured":"National Institute for Health and Care Excellence (2014) Antisocial behaviour and conduct disorders in children and young people. QS59. National Institute for Health and Care Excellence, London"},{"key":"780_CR11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1542\/peds.2012-0683","volume":"130","author":"D Dove","year":"2012","unstructured":"Dove D, Warren Z, McPheeters ML et al (2012) Medications for adolescents and young adults with autism spectrum disorders: a systematic review. Pediatrics 130:717\u2013726","journal-title":"Pediatrics"},{"key":"780_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s40489-014-0023-8","volume":"1","author":"J-D Lin","year":"2014","unstructured":"Lin J-D (2014) Medical care burden of children with autism spectrum disorders. Rev J Autism Dev Disord 1:242\u2013247","journal-title":"Rev J Autism Dev Disord"},{"key":"780_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40272-013-0016-6","volume":"15","author":"NB Almandil","year":"2013","unstructured":"Almandil NB, Liu Y, Murray ML et al (2013) Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Paediatr Drugs 15:139\u2013150","journal-title":"Paediatr Drugs"},{"key":"780_CR14","unstructured":"National Institute for Health and Care Excellence (2013) Autism: the management and support of children and young people on the autism spectrum. CG 170. National Institute for Health and Care Excellence, London"},{"key":"780_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1192\/bjp.bp.113.141267","volume":"205","author":"G Glover","year":"2014","unstructured":"Glover G, Bernard S, Branford D et al (2014) Use of medication for challenging behaviour in people with intellectual disability. Br J Psychiatry 205:6\u20137","journal-title":"Br J Psychiatry"},{"key":"780_CR16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","volume":"47","author":"E Simonoff","year":"2008","unstructured":"Simonoff E, Pickles A, Charman T et al (2008) Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 47:921\u2013929","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"780_CR17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/jep.12147","volume":"20","author":"S Every-Palmer","year":"2014","unstructured":"Every-Palmer S, Howick J (2014) How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract 20:908\u2013914","journal-title":"J Eval Clin Pract"},{"key":"780_CR18","unstructured":"US Department of Health and Human Services Aripiprazole: Pediatric Labeling Information. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Overview&DrugName=ABILIFY8 . Accessed 10 Jul 2015"},{"key":"780_CR19","unstructured":"US Department of Health and Human Services Risperidone\u202f: Pediatric Labeling Information. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Overview&DrugName=RISPERIDONE . Accessed 10 Jul 2015"},{"key":"780_CR20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/wps.20030","volume":"12","author":"E Taylor","year":"2013","unstructured":"Taylor E (2013) Pediatric psychopharmacology: too much and too little. World Psychiatry 12:124\u2013125","journal-title":"World Psychiatry"},{"key":"780_CR21","volume-title":"Multiaxial classification child and adolescent psychiatric disorders: the ICD-10 classification of mental and behavioural disorders in children and adolescents","author":"World Health Organisation","year":"2008","unstructured":"World Health Organisation (2008) Multiaxial classification child and adolescent psychiatric disorders: the ICD-10 classification of mental and behavioural disorders in children and adolescents. WHO, Cambridge"},{"key":"780_CR22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02211841","volume":"19","author":"C Lord","year":"1989","unstructured":"Lord C, Rutter M, Goode S et al (1989) Austism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 19:185\u2013212","journal-title":"J Autism Dev Disord"},{"key":"780_CR23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","volume":"368","author":"G Baird","year":"2006","unstructured":"Baird G, Simonoff E, Pickles A et al (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the special needs and autism project (SNAP). Lancet 368:210\u2013215","journal-title":"Lancet"},{"key":"780_CR24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","volume":"38","author":"R Goodman","year":"1997","unstructured":"Goodman R (1997) The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 38:581\u2013586","journal-title":"J Child Psychol Psychiatry"},{"key":"780_CR25","doi-asserted-by":"crossref","first-page":"e74262","DOI":"10.1371\/journal.pone.0074262","volume":"8","author":"C-Y Wu","year":"2013","unstructured":"Wu C-Y, Chang C-K, Robson D et al (2013) Evaluation of smoking status identification using electronic health records and open-text information in a large mental health case register. PLoS ONE 8:e74262","journal-title":"PLoS ONE"},{"key":"780_CR26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/schbul\/sbu120","volume":"41","author":"RD Hayes","year":"2015","unstructured":"Hayes RD, Downs J, Chang C-K et al (2015) The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders. Schizophr Bull 41:644\u2013655","journal-title":"Schizophr Bull"},{"key":"780_CR27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","volume":"40","author":"D Shaffer","year":"1983","unstructured":"Shaffer D, Gould MS, Brasic J et al (1983) A children\u2019s global assessment scale (CGAS). Arch Gen Psychiatry 40:1228\u20131231","journal-title":"Arch Gen Psychiatry"},{"key":"780_CR28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.biopsych.2007.01.001","volume":"61","author":"A Wagner","year":"2007","unstructured":"Wagner A, Lecavalier L, Arnold LE, Aman MG (2007) Developmental disabilities modification of the children\u2019s global assessment scale. Biol Psychiatry 61:504\u2013511","journal-title":"Biol Psychiatry"},{"key":"780_CR29","unstructured":"Department for Communities and Local Government English indices of deprivation 2010: technical report"},{"key":"780_CR30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004583-200111000-00015","volume":"40","author":"R Goodman","year":"2001","unstructured":"Goodman R (2001) Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry 40:1337\u20131345","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"780_CR31","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1542\/peds.2008-3713","volume":"124","author":"DM Rubin","year":"2009","unstructured":"Rubin DM, Feudtner C, Localio R, Mandell DS (2009) State variation in psychotropic medication use by foster care children with autism spectrum disorder. Pediatrics 124:e305\u2013e312","journal-title":"Pediatrics"},{"key":"780_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10597-012-9514-1","volume":"49","author":"AF Garland","year":"2013","unstructured":"Garland AF, Brookman-Frazee L, Gray E (2013) The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems. Community Ment Health J 49:507\u2013514","journal-title":"Community Ment Health J"},{"key":"780_CR33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00004583-200312000-00010","volume":"42","author":"LK Leslie","year":"2003","unstructured":"Leslie LK, Weckerly J, Landsverk J, Hough RL (2003) Racial\/ethnic differences in the use of psychotropic medication in high-risk children and adolescents. J Am Acad Child Adolesc Psychiatry 42:1433\u20131442","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"780_CR34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/ajp.2006.163.4.579","volume":"163","author":"SH Zuvekas","year":"2006","unstructured":"Zuvekas SH, Vitiello B, Norquist GS (2006) Recent trends in stimulant medication use among U.S. children. Am J Psychiatry 163:579\u2013585","journal-title":"Am J Psychiatry"},{"key":"780_CR35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/cap.2012.0026","volume":"23","author":"SK Drilea","year":"2013","unstructured":"Drilea SK, Jowers K, Lichtenstein C et al (2013) Psychotropic medication use and clinical outcomes among children and adolescents receiving system of care services. J Child Adolesc Psychopharmacol 23:36\u201343","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"780_CR36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/cap.2011.0057","volume":"21","author":"TW Frazier","year":"2011","unstructured":"Frazier TW, Shattuck PT, Narendorf SC et al (2011) Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 21:571\u2013579","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"780_CR37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/cap.2009.0120","volume":"20","author":"MG Aman","year":"2010","unstructured":"Aman MG, Kasper W, Manos G (2010) Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. J Child Adolesc Psychopharmacol 20:415\u2013422","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"780_CR38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/09638230600801462","volume":"15","author":"CJ Hawley","year":"2006","unstructured":"Hawley CJ, Littlechild B, Sivakumaran T (2006) Structure and content of risk assessment proformas in mental healthcare. J Ment Health 15:437\u2013448","journal-title":"J Ment Health"},{"key":"780_CR39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00787-012-0338-x","volume":"22","author":"P Waris","year":"2013","unstructured":"Waris P, Lindberg N, Kettunen K, Tani P (2013) The relationship between Asperger\u2019s syndrome and schizophrenia in adolescence. Eur Child Adolesc Psychiatry 22:217\u2013223","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"780_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00787-014-0576-1","volume":"24","author":"M Kyriakopoulos","year":"2015","unstructured":"Kyriakopoulos M, Stringaris A, Manolesou S et al (2015) Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis. Eur Child Adolesc Psychiatry 24:301\u2013307","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"780_CR41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004583-199801000-00022","volume":"37","author":"S Kumra","year":"1998","unstructured":"Kumra S, Jacobsen LK, Lenane M et al (1998) \u201cMultidimensionally impaired disorder\u201d: is it a variant of very early-onset schizophrenia? J Am Acad Child Adolesc Psychiatry 37:91\u201399","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"780_CR42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/cap.2005.15.510","volume":"15","author":"C Stayer","year":"2005","unstructured":"Stayer C, Sporn A, Gogtay N et al (2005) Multidimensionally impaired: the good news. J Child Adolesc Psychopharmacol 15:510\u2013519","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"780_CR43","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","volume":"162","author":"CJ McDougle","year":"2005","unstructured":"McDougle CJ, Scahill L, Aman MG et al (2005) Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 162:1142\u20131148","journal-title":"Am J Psychiatry"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-015-0780-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-015-0780-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-015-0780-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:06:09Z","timestamp":1553612769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-015-0780-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,15]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s00787-015-0780-7","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,15]]}}}